Zoopharmacognosy — when animals medicate themselves
Researchers have documented widespread evidence of wild animals deliberately selecting plants, soils and even insects with medicinal properties to treat or prevent illness, a behaviour formally termed "zoopharmacognosy."
The term combines Greek roots: "zoo" (animal), "pharmaco" (medicine/drug) and "gnosy" (knowledge), and was coined in 1987, building on earlier 1978 research on herbivores benefiting from plant secondary metabolites.
Documented cases span primates, bears, birds and invertebrates, showing animals use plants both prophylactically (when healthy, to prevent illness) and therapeutically (when already infected).
The field is drawing scientific attention for its potential to guide pharmaceutical drug discovery, particularly for parasitic infections and tumours.
Zoopharmacognosy: Definition and Mechanisms
Zoopharmacognosy is the behaviour by which non-human animals self-medicate by selecting and ingesting or topically applying plants, soils, and insects that have medicinal properties, to prevent or treat the harmful effects of pathogens, toxins, or parasites. Animals use three broad mechanisms: deglutition (swallowing whole leaves/seeds that mechanically expel parasites without being digested), topical application (rubbing crushed plant or insect material on skin/fur for wound care or insect repellence), and ingestion of bioactive secondary metabolites (chemical compounds like alkaloids or terpenes that have antiparasitic or antimicrobial effects).
Key Details
- The term was coined in 1987, drawing on 1978 research proposing that herbivores derive medicinal benefit from plant secondary metabolites.
- The behaviour is documented across primates, birds, mammals and even invertebrates like insects.
- Zoopharmacognosy is distinguished from normal foraging in that the selected material has low or no nutritional value but demonstrable medicinal effect.
The article frames zoopharmacognosy as the umbrella scientific term for the self-medicating behaviours described, situating specific animal examples (chimpanzees, bears, birds, insects) within this single unifying concept.
Primate Self-Medication and Ethnopharmacology
Chimpanzees are documented chewing the bitter pith of Vernonia amygdalina, a plant containing compounds active against parasites such as Schistosoma, Plasmodium (the malaria-causing parasite) and Leishmania. Bonobos and gorillas similarly consume medicinal plants with little nutritional value purely for their pharmacological effects. This primate behaviour is studied under "ethnopharmacology" and "zoopharmacognosy," and has directly informed human traditional medicine in regions where local communities observed and adopted these plant uses.
Key Details
- Vernonia amygdalina (bitter leaf) contains sesquiterpene lactones and other compounds with antiparasitic activity.
- Plasmodium is the genus of parasite that causes malaria in humans; Leishmania causes leishmaniasis, a neglected tropical disease.
- Observations of primate self-medication have contributed to bioprospecting for new antiparasitic and anticancer compounds.
Chimpanzee bitter-pith chewing is cited as a classic example showing how animal self-medication observations can point researchers toward pharmacologically active plant compounds.
Other Animal Examples and Conservation Relevance
Beyond primates, Alaskan brown bears swallow rough-textured Carex (sedge) leaves before hibernation to mechanically expel tapeworms; parrots consume kaolin clay, likely to bind toxins and aid digestion; starlings line their nests with wild carrot to reduce mite infestations; and woolly bear caterpillars ingest pyrrolizidine alkaloids to resist parasitic flies. These behaviours illustrate animal-environment co-adaptation and are relevant to biodiversity conservation, since loss of specific plant species from an ecosystem can remove a self-medication resource critical to wildlife health.
Key Details
- Kaolin clay ingestion by birds and other animals is also studied as "geophagy" (soil-eating for mineral supplementation and toxin binding).
- Pyrrolizidine alkaloids are plant-derived toxic compounds that, in controlled doses, act as an anti-parasitic defence for the ingesting animal.
These diverse examples across taxa (mammals, birds, insects) demonstrate that zoopharmacognosy is a broad, cross-species phenomenon relevant to both biodiversity science and applied pharmacology.
- Term "zoopharmacognosy" coined in 1987; conceptual groundwork on plant secondary metabolites dates to 1978.
- Chimpanzee bitter-pith source: Vernonia amygdalina, active against Schistosoma, Plasmodium and Leishmania.
- Alaskan brown bears use Carex (sedge) leaves to expel tapeworms pre-hibernation.
- Documented across at least four taxa groups: primates (chimpanzees, bonobos, gorillas), mammals (bears), birds (parrots, starlings), and invertebrates (woolly bear caterpillars).
- The field's core applications: parasitic disease treatment and potential tumour/cancer-related drug discovery.